TScan Therapeutics, Inc. (TCRX)
0.16 USD-4.40%close 2026-11-13Healthcare
Gurus hold—none of the tracked superinvestors
Net buying (quarter)—latest quarter, superinvestors
Market Cap$20.9M52 Week Range: 0.16 – 1.43
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossEPS -0.88
The live quote provider is unreachable; the last known close is shown.
TScan Therapeutics, Inc. (TCRX) is not among the 30 most-held stocks of the tracked superinvestor set. Price 0.16 USD; market cap $20.9M.
Price & valuation
Prev Close0.17
Open—
Day Range—
52 Week Range0.16 – 1.43
Volume—
Avg Volume (3M)—
BetaVolatility vs the market. Above 1: swings harder than the index.1.922 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossSEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.—
Pro Feature
This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.
Upgrade to ProAbout
SectorHealthcare
Industry—
Employees—
Website—
Frequently Asked Questions
Which superinvestors own TCRX?
TScan Therapeutics, Inc. (TCRX) is not among the 30 most-held stocks of the tracked superinvestor set.
Is institutional sentiment on TCRX bullish or bearish?
TCRX is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.